Quell Therapeutics and Cellistic™ enter a strategic collaboration to develop an iPSC-derived allogeneic T-regulatory (Treg) cell therapy platform

- Collaboration combines Quell's pioneering autologous multi-modular Treg cell therapy platform and Cellistic™'s expertise in iPSC cell therapy platform...

Related Keywords

Gosselies ,Waals Gewest ,Belgium ,London ,City Of ,United Kingdom ,Andy Holt ,Eleanor Perkin ,Luke Henry ,Iain Mcgill ,Ncardia Cellistic ,Tracey Lodie ,Stefan Braam ,Christina Tartaglia ,Sandi Greenwood ,Stern Investor Relations Inc ,Therapeutics Ltd ,Quell Therapeutics Ltd ,Chief Executive Officer ,Quell Therapeutics ,Chief Scientific Officer ,Chief Business ,Mark Swallow ,Investor Relations ,Chief Commercial ,Quell Therapeutics And Cellistic ,